|
|
|
|
| LEADER |
01142caa a2200313 i 4500 |
| 001 |
NSK01000785741 |
| 003 |
HR-ZaNSK |
| 005 |
20130108112910.0 |
| 007 |
ta |
| 008 |
111110s2010 ci | |||| ||eng |
| 035 |
|
|
|a (HR-ZaNSK)000785741
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
|
|
|a 615
|2 MRF 1998.
|
| 100 |
1 |
|
|a Agius, Mark
|
| 245 |
1 |
0 |
|a What do large scale studies of medication in Schizophrenia add to our management strategies? /
|c Mark Agius, Abigail Davis, Michael Gilhooley, Shelley Chapman & Rashid Zaman.
|
| 300 |
|
|
|b Ilustr.
|
| 500 |
|
|
|a 12th Central European Neuropsychopharmacological Symposium, Zagreb, May 7-8, 2010
|
| 504 |
|
|
|a Bibliografija: 10 jed.
|
| 653 |
|
0 |
|a Shizofrenija
|a Antipsihotici
|
| 700 |
1 |
|
|a Davis, Abigail
|
| 700 |
1 |
|
|a Gilhooley, Michael
|
| 700 |
1 |
|
|a Chapman, Shelley
|
| 700 |
1 |
|
|a Zaman, Rashid
|
| 773 |
0 |
|
|t Psychiatria Danubina
|x 0353-5053
|g 22 (2010), 2 ; str. 323-328
|
| 981 |
|
|
|b B09/10
|p CRO
|
| 998 |
|
|
|a rado111110
|c vol1o130108
|
| 856 |
4 |
2 |
|u http://hrcak.srce.hr/index.php?show=clanak&id_clanak_jezik=84839
|y Elektronička verzija članka
|